{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:52:57Z","timestamp":1792090377895,"version":"4.4.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136746","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T18:22:58Z","timestamp":1440786178000},"page":"e0136746","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ribavirin Inhibits the Activity of mTOR\/eIF4E, ERK\/Mnk1\/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia"],"prefix":"10.1371","volume":"10","author":[{"given":"Fangfang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Len","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duolan","family":"Naren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-10-2334","article-title":"Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer","volume":"17","author":"F Pettersson","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1158\/0008-5472.CAN-08-3472","article-title":"eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival","volume":"69","author":"JR Graff","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2009-02-205153","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"S Assouline","year":"2009","journal-title":"Blood"},{"issue":"52","key":"ref4","doi-asserted-by":"crossref","first-page":"18105","DOI":"10.1073\/pnas.0406927102","article-title":"Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap","volume":"101","author":"A Kentsis","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-010-0233-6","article-title":"Inhibition of eIF4E phosphorylation reduces cell growth and proliferation in primary central nervous system lymphoma cells","volume":"101","author":"D Muta","year":"2011","journal-title":"J Neurooncol"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1158\/1078-0432.CCR-10-0433","article-title":"Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer","volume":"16","author":"AC Hsieh","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"N Sonenberg","year":"2009","journal-title":"Cell"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4161\/cc.7.5.5486","article-title":"MNK, EIF4E and targeting translation for therapy","volume":"7","author":"RL Silva","year":"2008","journal-title":"Cell Cycle"},{"issue":"32","key":"ref9","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1073\/pnas.1008908107","article-title":"Mnk earmarks eIF4E for cancer therapy","volume":"107","author":"N Hay","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"ref10","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"HG Wendel","year":"2007","journal-title":"Genes Dev"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/leu.2011.57","article-title":"Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens","volume":"25","author":"BC Kraljacic","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2008.07.163","article-title":"Ribavirin targets eIF4E dependent Akt survival signaling","volume":"375","author":"K Tan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1083\/jcb.200707018","article-title":"The eIF4E RNA regulon promotes the Akt signaling pathway","volume":"181","author":"B Culjkovic","year":"2008","journal-title":"J Cell Biol"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1261\/rna.2238705","article-title":"Further evidence that ribavirin interacts with eIF4E","volume":"11","author":"A Kentsis","year":"2005","journal-title":"RNA"},{"issue":"6","key":"ref15","first-page":"1971","article-title":"Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation","volume":"29","author":"S K\u00f6k\u00e9ny","year":"2009","journal-title":"Anticancer Res"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity","volume":"189","author":"S Li","year":"1999","journal-title":"J Exp Med"},{"issue":"13","key":"ref17","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"BJ Druker","year":"2008","journal-title":"Blood"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","article-title":"Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study","volume":"109","author":"A Labarthe","year":"2007","journal-title":"Blood"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study GroupJ","volume":"24","author":"M Yanada","year":"2006","journal-title":"Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2011.1.231","article-title":"Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"2011","author":"AK Fielding","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.25690","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives","volume":"117","author":"HJ Lee","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/CAD.0000000000000200","article-title":"The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia","volume":"26","author":"F Shi","year":"2015","journal-title":"Anticancer Drugs"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.onc.1209901","article-title":"A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation","volume":"26","author":"S Prabhu","year":"2007","journal-title":"Oncogen"},{"issue":"5","key":"ref24","first-page":"314","article-title":"The calculation of ID50 in new drugs with software SPSS","volume":"27","author":"YP Zhou","year":"2003","journal-title":"Prog Pharm Sci"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4161\/cbt.21460","article-title":"Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN\/mTOR signaling pathway","volume":"13","author":"Y Guo","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-8722-6-18","article-title":"SNS-032 inhibits mTORC1\/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt","volume":"6","author":"H Meng","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood-2008-10-184515","article-title":"Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia","volume":"114","author":"J Tamburini","year":"2009","journal-title":"Blood"},{"issue":"20","key":"ref28","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/MCB.00477-08","article-title":"Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance","volume":"28","author":"M Zhang","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/mt.2010.145","article-title":"MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus","volume":"18","author":"C Goetz","year":"2010","journal-title":"Mol Ther"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1095\/biolreprod.110.085050","article-title":"Differential contribution of the MTOR and MNK pathways to the regulation of mRNA translation in meiotic and postmeiotic mouse male germ cells","volume":"83","author":"V Messina","year":"2010","journal-title":"Biol Reprod"},{"issue":"15","key":"ref31","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1158\/0008-5472.CAN-10-4531","article-title":"Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition","volume":"71","author":"JL Coloff","year":"2011","journal-title":"Cancer Res"},{"issue":"52","key":"ref32","doi-asserted-by":"crossref","first-page":"36344","DOI":"10.1074\/jbc.M803580200","article-title":"Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation","volume":"283","author":"Y Zhao","year":"2008","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T23:44:31Z","timestamp":1567122271000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136746"}},"subtitle":[],"editor":[{"given":"Connie J","family":"Eaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136746","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}